{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:10:52Z","timestamp":1784128252381,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"cience and Technology Department of Jilin province","award":["0150101128JC"],"award-info":[{"award-number":["0150101128JC"]}]},{"name":"cience and Technology Department of Jilin province","award":["20130206050YY"],"award-info":[{"award-number":["20130206050YY"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.prp.2017.01.022","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T06:46:02Z","timestamp":1486190762000},"page":"848-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7\/adriamycin cells"],"prefix":"10.1016","volume":"213","author":[{"given":"Chun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haogang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.01.022_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA-Cancer J. Clin."},{"key":"10.1016\/j.prp.2017.01.022_bib0010","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3892\/etm.2014.1662","article-title":"Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells","volume":"7","author":"Huang","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2017.01.022_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12094-014-1169-7","article-title":"Compounds from Chinese herbal medicines as reversal agents for P-glycoprotein-mediated multidrug resistance in tumours","volume":"16","author":"Li","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.prp.2017.01.022_bib0020","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.3390\/molecules190913848","article-title":"Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance","volume":"19","author":"Anreddy","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2017.01.022_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2017.01.022_bib0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012875105006","article-title":"The mechanism of action of multidrug-resistance-linked P-glycoprotein","volume":"33","author":"Sauna","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.prp.2017.01.022_bib0035","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.prp.2017.01.022_bib0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/his.12035","article-title":"Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells","volume":"62","author":"Yagi","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2017.01.022_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0889-8588(18)30095-9","article-title":"P-glycoprotein in adult solid tumors. Expression and prognostic significance","volume":"9","author":"Leighton","year":"1995","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.prp.2017.01.022_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0889-8588(18)30094-7","article-title":"P-glycoprotein in adult hematologic malignancies","volume":"9","author":"Marie","year":"1995","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.prp.2017.01.022_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jnci\/83.2.111","article-title":"Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma","volume":"83","author":"Verrelle","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2017.01.022_bib0060","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2017.01.022_bib0065","first-page":"1446","article-title":"Effect of Bupleurun chinese DC(BCDC) on the MDR reversal of hepatocellular carcinoma and related mechanism","volume":"26","author":"Gai","year":"2005","journal-title":"Gao Deng Xue Xiao Hua Xue Bao."},{"key":"10.1016\/j.prp.2017.01.022_bib0070","first-page":"76","article-title":"Reverse effects of saikoside on multidrug resistance of human leukemic cell line K562\/ADM in vitro","volume":"28","author":"Gai","year":"2012","journal-title":"Zhongguo Bing Li Sheng Li Za Zhi"},{"key":"10.1016\/j.prp.2017.01.022_bib0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.intimp.2012.06.010","article-title":"Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-\u03baB signaling pathway","volume":"14","author":"Lu","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.prp.2017.01.022_bib0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5582\/ddt.2013.v7.6.212","article-title":"Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection","volume":"7","author":"Qi","year":"2013","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.prp.2017.01.022_bib0085","first-page":"2435","article-title":"Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest","volume":"18","author":"Liu","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2017.01.022_bib0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-003-0742-5","article-title":"Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance","volume":"53","author":"Fu","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.prp.2017.01.022_bib0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2017.01.022_bib0100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.febslet.2005.12.060","article-title":"The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research","volume":"580","author":"Gottesman","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2017.01.022_bib0105","first-page":"418","article-title":"Multidrug resistance of acute leukemia and a strategy to overcome it","volume":"72","author":"Motoji","year":"2000","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.prp.2017.01.022_bib0110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood.V84.1.262.262","article-title":"Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies","volume":"84","author":"Merlin","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.prp.2017.01.022_bib0115","first-page":"40","article-title":"Pharmacologic approaches to reversing multidrug resistance","volume":"34","author":"Sikic","year":"1997","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.prp.2017.01.022_bib0120","first-page":"749","article-title":"In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576","volume":"61","author":"Mistry","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2017.01.022_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.prp.2017.01.022_bib0130","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1023\/A:1025092829696","article-title":"Rapid assessment of P-glycoprotein inhibition and induction in vitro","volume":"20","author":"Perloff","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.prp.2017.01.022_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/bcr303","article-title":"Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line","volume":"3","author":"Li","year":"2001","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2017.01.022_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.04.107","article-title":"Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells","volume":"358","author":"Yu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2017.01.022_bib0145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tiv.2008.01.004","article-title":"Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line","volume":"22","author":"Klamt","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.prp.2017.01.022_bib0150","doi-asserted-by":"crossref","first-page":"e98560","DOI":"10.1371\/journal.pone.0098560","article-title":"Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816305210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033816305210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T19:59:29Z","timestamp":1601582369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033816305210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0344033816305210"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.01.022","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7\/adriamycin cells","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}